Can Preoperative PET/CT SUVmax Predict Aggressive Pathological Features in Non-Small Cell Lung Cancer? A Retrospective Cohort Study of STAS, LVI, and VPI

Abstract Background Spread through air spaces (STAS), lymphovascular invasion (LVI), and visceral pleural invasion (VPI) are adverse prognostic features in non-small cell lung cancer (NSCLC) that can only be assessed postoperatively. This study evaluated whether preoperative primary tumor SUVmax on 18F-FDG PET/CT independently predicts these features. Methods In this retrospective cohort of 478 patients undergoing surgical resection for NSCLC, associations between primary tumor SUVmax and STAS, LVI, and VPI were assessed using univariate and multivariable logistic regression, adjusted for tumor size, histologic subtype, and other clinically relevant covariates. Discriminative performance was evaluated using receiver operating characteristic (ROC) curve analysis. Results STAS, LVI, and VPI were present in 269 (56.3%), 237 (49.6%), and 202 (42.3%) patients, respectively. SUVmax was independently associated with all three outcomes: STAS (adjusted OR = 1.051, 95% CI 1.020–1.083, p = 0.001), LVI (adjusted OR = 1.083, 95% CI 1.048–1.119, p < 0.001), and VPI (adjusted OR = 1.044, 95% CI 1.015–1.073, p = 0.002). Discriminative performance was acceptable for LVI (AUC = 0.701) but weak for STAS (AUC = 0.578) and VPI (AUC = 0.584). Sensitivity analyses excluding neoadjuvant-treated patients and interaction testing confirmed these associations were independent of neoadjuvant treatment status. Conclusion Preoperative SUVmax is independently associated with STAS, LVI, and VPI in resected NSCLC, most strongly for LVI. Although its standalone discriminative value is limited, SUVmax—already available at diagnosis—may contribute to multivariable preoperative risk stratification alongside histologic subtype and tumor size.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-03
DOI
https://doi.org/10.21203/rs.3.rs-11393226/v1
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Can Preoperative PET/CT SUVmax Predict Aggressive Pathological Features in Non-Small Cell Lung Cancer? A Retrospective Cohort Study of STAS, LVI, and VPI

Ahmet Kayahan Tekneci, Ufuk Çağırıcı, Tevfik İlker Akçam, Ayse Gul Ergonul et al.
1 links
Research Square
Lung Cancer Diagnosis and Treatment
preprint

Can Preoperative PET/CT SUVmax Predict Aggressive Pathological Features in Non-Small Cell Lung Cancer? A Retrospective Cohort Study of STAS, LVI, and VPI

Ahmet Kayahan Tekneci, Ufuk Çağırıcı, Tevfik İlker Akçam, Ayse Gul Ergonul, Hasan Yavuz, Alpaslan Çakan, Gizem Kececi Ozgur, Kutsal Turhan
preprint en

Abstract

Abstract Background Spread through air spaces (STAS), lymphovascular invasion (LVI), and visceral pleural invasion (VPI) are adverse prognostic features in non-small cell lung cancer (NSCLC) that can only be assessed postoperatively. This study evaluated whether preoperative primary tumor SUVmax on 18F-FDG PET/CT independently predicts these features. Methods In this retrospective cohort of 478 patients undergoing surgical resection for NSCLC, associations between primary tumor SUVmax and STAS, LVI, and VPI were assessed using univariate and multivariable logistic regression, adjusted for tumor size, histologic subtype, and other clinically relevant covariates. Discriminative performance was evaluated using receiver operating characteristic (ROC) curve analysis. Results STAS, LVI, and VPI were present in 269 (56.3%), 237 (49.6%), and 202 (42.3%) patients, respectively. SUVmax was independently associated with all three outcomes: STAS (adjusted OR = 1.051, 95% CI 1.020–1.083, p = 0.001), LVI (adjusted OR = 1.083, 95% CI 1.048–1.119, p < 0.001), and VPI (adjusted OR = 1.044, 95% CI 1.015–1.073, p = 0.002). Discriminative performance was acceptable for LVI (AUC = 0.701) but weak for STAS (AUC = 0.578) and VPI (AUC = 0.584). Sensitivity analyses excluding neoadjuvant-treated patients and interaction testing confirmed these associations were independent of neoadjuvant treatment status. Conclusion Preoperative SUVmax is independently associated with STAS, LVI, and VPI in resected NSCLC, most strongly for LVI. Although its standalone discriminative value is limited, SUVmax—already available at diagnosis—may contribute to multivariable preoperative risk stratification alongside histologic subtype and tumor size.

Research Square
Ege Üniversitesi Tıp Fakültesi Hastanesi (TR), Amerikan Hastanesi (TR)
Good health and well-being
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon